- Home
- PUK vs SLRX Comparison
PUK vs SLRX Comparison
Compare PUK & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUK
- SLRX
- Stock Information
- Founded
- PUK 1848
- SLRX N/A
- Country
- PUK Hong Kong
- SLRX United States
- Employees
- PUK N/A
- SLRX N/A
- Industry
- PUK Life Insurance
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- PUK Finance
- SLRX Health Care
- Exchange
- PUK Nasdaq
- SLRX Nasdaq
- Market Cap
- PUK N/A
- SLRX 1.7M
- IPO Year
- PUK 1990
- SLRX N/A
- Fundamental
- Price
- PUK $22.84
- SLRX $0.76
- Analyst Decision
- PUK
- SLRX
- Analyst Count
- PUK 0
- SLRX 0
- Target Price
- PUK N/A
- SLRX N/A
- AVG Volume (30 Days)
- PUK 757.2K
- SLRX 28.0K
- Earning Date
- PUK 03-19-2025
- SLRX 05-14-2025
- Dividend Yield
- PUK 2.02%
- SLRX N/A
- EPS Growth
- PUK 35.70
- SLRX N/A
- EPS
- PUK 0.84
- SLRX N/A
- Revenue
- PUK $12,256,000,000.00
- SLRX N/A
- Revenue This Year
- PUK $131.26
- SLRX N/A
- Revenue Next Year
- PUK $13.17
- SLRX N/A
- P/E Ratio
- PUK $12.87
- SLRX N/A
- Revenue Growth
- PUK 11.04
- SLRX N/A
- 52 Week Low
- PUK $14.39
- SLRX $0.45
- 52 Week High
- PUK $23.35
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- PUK 59.09
- SLRX 46.97
- Support Level
- PUK $22.42
- SLRX $0.68
- Resistance Level
- PUK $22.76
- SLRX $0.84
- Average True Range (ATR)
- PUK 0.27
- SLRX 0.05
- MACD
- PUK -0.09
- SLRX 0.00
- Stochastic Oscillator
- PUK 57.85
- SLRX 1.60
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.